11 July 2022 | News
The gel is India's first topical minocycline and can be safely used for patients above nine years
Mumbai-based Glenmark Pharmaceuticals has launched India’s first topical Minocycline 4 per cent gel for the treatment of moderate to severe acne, under the brand name MINYM.
This is a potent anti-bacterial gel which exerts a strong anti-inflammatory action It also offers the lowest MIC90 (minimum Inhibitory Concentration at which it stops/prevents visible growth of 90 per cent of isolates of bacteria) compared to the available topical antibacterial formulations.
MINYM Gel (Topical Minocycline 4 per cent gel) has been developed to address these growing concerns in the treatment of acne and is safe to use in patients above nine years of age.
In a study conducted by Glenmark in 2020, on the prevalence of acne in India, it was observed that 45 percent of the patients were males and 55 percent were females; and almost 72 percent of the patients were in the adolescent group whereas 27 percent patients were in the adult group.